http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021506891-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate | 2018-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021506891-A |
| titleOfInvention | Amide-substituted imidazole [4,5-C] quinoline compounds with branched chain linking groups for use as immune response regulators |
| abstract | An imidazo [4,5-c] quinoline compound having an alkylamide substituent attached to the N-1 position by a branched chain linking group, a single enantiomer of this compound, a pharmaceutical composition containing this compound, and this compound. Disclose the manufacturing method of. Also disclosed are methods of using this compound as an immune response regulator to induce cytokine biosynthesis in humans and animals, and in the treatment of diseases, including infectious and neoplastic diseases. Equation (I) |
| priorityDate | 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 178.